01 1Alembic Pharmaceuticals Limited
01 1NELARABINE
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2023-03-22
Pay. Date : 2023-03-01
DMF Number : 37544
Submission : 2022-11-30
Status : Active
Type : II
20
Alembic Pharmaceuticals Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is NELARABINE, with a corresponding US DMF Number 37544.
Remarkably, this DMF maintains an Active status since its submission on November 30, 2022, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of March 22, 2023, and payment made on March 01, 2023, indicating their dedication to facilitating drug approvals, Categorized as Type II
